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Disposable Biosensors for Clinical Diagnosis
Bruno Campos Janegitz, Juliana Cancino, and Valtencir Zucolotto∗
Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos,
University of São Paulo, CP 369, 13560-970 São Carlos, SP, Brazil
We present an overview on the use of disposable electrochemical biosensors for diagnostics, focus-
ing on the applications of these devices as immunosensors and DNA sensors in the point-of-care
diagnostics. Analytical biosensors have emerged as efﬁcient alternatives for the detection of innu-
merous diseases, because of their high speciﬁcity and the convenience of detecting the electro-
chemical signals produced by the presence of an analyte using a portable equipment. This review
highlights the recently developed strategies toward immobilization of different biological molecules
on disposable electrodes such as carbon nanotubes and metal nanoparticles. In the course of the
review, we ﬁrst introduced the disposable biosensors, followed by an overview of the immunosen-
sors, and discussed the applications of DNA sensors and disposable biosensors in point-of-care
diagnostics. We also have evaluated the prospects and future applications of these devices in the
ﬁeld of biomedical research.
Keywords: Nanomedicine, Nanotoxicology, Electrochemical Biosensors, Disposable Electrodes,
Biomedical Analysis, Screen-Printed Electrodes.
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1. INTRODUCTION
Biosensors are analytical devices that ﬁnd applications
in different areas, including clinical analysis as well as
food and environmental control. The beneﬁts of using
biosensors can be attributed to their simple preparation
procedures, relatively low cost, versatility, and selectiv-
ity for quantiﬁcation of various compounds of interest.
Furthermore, the miniaturization of detection systems and
development of disposable sensor units have also attracted
considerable attention.12
A biosensor is a highly selective recognition device,
wherein a transducer transforms the signal generated in
the reaction of the analyte with a biological element such
as an immobilized enzyme,3–11 antibody/antigen,512 plant
or animal tissue, or a microorganism into an electronically
∗Author to whom correspondence should be addressed.
measurable signal.13–15 Various analytes of environmen-
tal, medical, biological, pharmaceutical, or industrial inter-
est can be monitored using an electrochemical biosensor,
which provides a measure of the analyte concentration by
detecting the current generated in the oxidation or reduc-
tion of the redox species.16 In electrochemical biosen-
sors, the biological material is directly immobilized on
a electrode by adsorption, covalent bonding, or encapsu-
lation within a coating layer of a permeable conductive
polymer or cross-linked reagent.1718 These diverse strate-
gies of immobilization lead to biosensors with different
architectures such as monolayer,1920 multilayers21 and thin
ﬁlms.2223
Though a number of electrochemical biosensors have
been developed using nondisposable electrodes like glassy
carbon,24 boron doped diamond electrodes,9 or pyrolytic
carbon25 as the transduction platform, disposable biosen-
sors with screen-printed chip, indium tin oxide (ITO),
and pencil graphite electrodes are extensively used in
medical diagnoses.26 These devices are inexpensive, easy
to fabricate, and can be effectively used for routine
analysis. Development of new architectures for biosen-
sors employing nanostructured materials including carbon
nanotubes,2728 metal nanoparticles,29–34 and graphene35
have attracted considerable interest.36 Immobilization of
biological molecules on these electrode platforms reduces
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the overpotential by promoting electron transfer, resulting
in an improved analytical response.
Recently, the applications of several disposable
electrochemical biosensors such as DNA biosensors
and immunosensors in medical analyses have been
proposed.37–39 In this paper, we present a review of the
disposable electrochemical biosensors for medical analy-
ses based on the reported developments over the recent
5 years, with emphasis on their design, materials and meth-
ods for construction, as well as their applications in med-
ical areas.
2. DISPOSABLE IMMUSENSORS
Immunosensors are a class of biosensors based on the
transduction of signals generated in antigen-antibody inter-
actions. Design and preparation of an ideal interface
between the biomaterial and the detector is a fundamen-
tal requirement for the development of immunosensors.40
The antigen of interest is investigated by detecting the
labeled antibodies and/or labeled antigens after the forma-
tion of antigen-antibody complexes.39 These devices are
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advantageous because of their fast response and simplicity
of operation. Two types of voltammetric and amperomet-
ric immunosensors are known, which employ “sandwich”-
type and competitive-type immunoassays, as shown in
Figure 1. Impedimetric immunosensors also determine the
concentration of the antigen of interest by detecting the
impedance generated on the addition of antibodies.
In sandwich-type immunosensors,41 the primary anti-
bodies ﬁrst bind to the transducer material, followed by the
addition of antigens, and ﬁnally, the enzyme-labeled anti-
bodies react with the substrate to form antigen-antibody
complexes. Competitive-type immunosensors, on the other
hand, are based on the competitive interactions of labeled
and unlabeled antigens with the substance of interest reacts
with the substrate.42 In this case, binding of the pri-
mary antibodies to the transducer material is followed by
the addition of enzyme-labeled antigens to form antigen-
antibody complexes. The quantiﬁcation is performed by
the controlled addition of labeled and unlabeled antigens.
Several disposable electrochemical immunosensors
using different electroactive materials such as conducting
polymers,43 graphite,44 carbon nanotubes,45 or metals4647
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Figure 1. Immunosensors employing sandwich-type (A) and
competitive-type (B) immunoassays. In (A), the primary antibodies ﬁrst
bind to the transducer material, followed by the addition of antigens,
and ﬁnally, the enzyme-labeled antibodies react with the substrate to
form antigen-antibody complexes. In (B), the immunosensors are based
on the competitive interactions of labeled and unlabeled antigens.
have been reported in the literature. A number of dispos-
able immunosensor arrays have been developed for the
electrochemical determination of tumor markers. Recently,
a disposable immunosensor array was fabricated using cel-
lulose acetate membrane, thionine, and two types of anti-
gens immobilized on carbon electrodes of a screen-printed
chip.48 Several tumor markers were simultaneously inves-
tigated by a multianalyte test with a direct capture format,
using horseradish peroxidase-labeled antibodies immobi-
lized on screen-printed carbon electrodes modiﬁed with
gold nanoparticles.49 This system can be applied in the
accurate, point-of-care detection of carcinoma antigen 153,
carcinoma antigen 125, carbohydrate antigen 199, and
carcinoembryonic antigen in clinical serum samples with
detection limits of 0.2 kU L−1, 0.5 kU L−1, 0.3 kU L−1,
and 0.1 mu g L−1, respectively.
Disposables sensors have been proposed by Ho et al.50
and Viswanathan et al.51 for the detection of the car-
cinoembryonic antigen, a tumor marker. In the former,
the authors have proposed a sensitive electrochemical
immunosensor based on a carbon nanoparticle-modiﬁed
screen-printed graphite electrode covered with speciﬁc
antibodies, using CdS nanocrystals as biotracers as a
strategy for signal ampliﬁcation. The system has shown
promise for home-care self-diagnostic tool, with a detec-
tion limit of 32 pg mL−1. In the latter paper, the authors
used ferrocene liposomes and multiwalled carbon nano-
tubes screen-printed electrode to detect carcinoembryonic
antigens. They have employed square wave voltamme-
try to study the redox response of the released ferrocene
carboxylic acid from the immunoconjugated liposomes
present on the electrode surface. A detection limit of
1.0 pg mL−1 was reported.
Lin et al. have been reported a competitive electrochem-
ical immunosensor to detect polychlorinated biphenyls52
(labeled with horseradish peroxidase), which performed a
sensitive immunoassay based on disposable screen-printed
electrodes modiﬁed magnetic beads with a detection
limit of 10 pg mL−1. A new sensitive electrochemical
immunosensor has been proposed by Huang et al,53 to
detect the carcinoembryonic antigen using a composite
electrode containing Au nanoparticles, multi-walled car-
bon nanotubes and chitosan. The electrode presented a
detection limit of 0.01 ng mL−1, which can be applied
in the diagnosis and in the monitoring of this type of
carcinoma.
A modern and simple electrochemical immunosensor
based on paper sensors with an addressable electrode array
has been proposed by Ge et al.54 The authors designed an
interesting method to determine individually different tar-
gets using a unique device consisting of an arrange of 24
measurement points in a polyethylene terephthalate sub-
strate. This disposable array has shown promise to detect
four different tumor markers, viz.: -fetoprotein, cancer
antigen 125, cancer antigen 153 and carcinoembryonic
antigen, with detection limits of 15×10−4 ng mL−1, 37×
10−5 U mL−1, 26×10−5 U mL−1 and 20×10−5 ng mL−1,
respectively.
Gold nanoparticles have been extensively used for
the detection of different antigens in immunoassays. La
Belle et al. proposed a label-free disposable electro-
chemical biosensor modiﬁed with gold nanoparticles for
the detection of interleukin-12, an important analyte for
diagnosis of multiple sclerosis.55 Lai et al. designed
an electrochemical immunosensor (Fig. 2) using glucose
oxidase-functionalized antibodies immobilized on screen-
printed carbon electrodes modiﬁed with Prussian blue
and gold nanoparticles attached to carbon nanotubes, for
the sensitive simultaneous multiplexed detection of tumor
markers.56 Another immunosensor was developed by Lai
et al. for the multiplexed detection of tumor markers,
using covalent immobilization of antibodies on chitosan-
modiﬁed screen-printed carbon electrodes containing silver
and gold nanoparticles.57
An inexpensive and efﬁcient immunosensor was
designed for detection of cancer biomarker proteins using
the gold-covered side of compact discs,58 on which the
authors prepared a immunoarray comprising 8 electrodes
into a microﬂuidic device. The authors carried out a sand-
wich immunoassay for interleukin 6 detection that exhib-
ited a detection limit of 10 fg mL−1. Ho et al. have
developed an electrochemical sandwich immunosensor for
the detection of the antigen -enolase -associated with
human lung cancer59-based upon the adsorption of anti-
-enolase monoclonal antibody on polyethylene glycol-
modiﬁed disposable screen-printed electrodes (Fig. 3).
380 J. Nanosci. Nanotechnol. 14, 378–389, 2014
Delivered by Publishing Technology to: UNIVERSIDADE SAO PAULO IF
IP: 143.107.180.158 On: Tue, 28 Jan 2014 12:09:03
Copyright: American Scientific Publishers
Janegitz et al. Disposable Biosensors for Clinical Diagnosis
Figure 2. Schematic representation of a carbon nanotube-based immunosensor, as proposed by Lai et al. Reprinted with permission from [56], G. S.
Lai, et al., Anal. Chem. 81, 9730 (2009). © 2009, American Chemical Society.
The detection system exhibited a detection limit of
2.38 pg mL−1. Disposable arrays have been also devel-
oped for the detection of prostate-cancer-speciﬁc anti-
gens, using magnetic-microparticle-modiﬁed antibodies
coupled to multiplexed electrochemical screen-printed
electrodes.60 Arrays containing 8 electrodes have been pre-
pared using antibody-modiﬁed magnetic microparticles to
abtain a sensitive immunosensor with a detection limit of
1.4 ng mL−1.
Screen-printed carbon electrodes have several advan-
tages because of their reasonable price and usability
in a wide range of potentials as well as in several
media. The applications of screen-printed carbon elec-
trodes in the detection of a variety of proteins such as
phosphorylated acetyl cholinesterase,61 Shigella ﬂexneri,62
urine albumin,63 mycotoxin ochratoxin A,64 and in the
determination of Escherichia coli65 have been reported.
Using a similar strategy, Zhang et al. have proposed an
Figure 3. Operation of an electrochemical immunosensor for detection of Human Lung Cancer-Associated Antigen, -enolase. Reprinted with
permission from [50], J. A. A. Ho, et al., Anal. Chem. 82, 5944 (2010). © 2010, American Chemical Society.
electrochemical immunosensor for the determination of
microcystin-LR using a double-sided microporous gold
electrode in cartridge-type cells.66 Presenting a detection
limit of 100 pg mL−1, the biosensor was applied in
the determination of relevant analytes in environmental
samples.
An impedimetric electrochemical immunosensor based
upon printed circuit electrodes67 was developed and
applied in the determination of interleukin-12. The
immunosensors could detect interleukin-12 at physio-
logical levels. Konstantinov et al. have been designed
a portable electrochemical immunosensor for the rapid
detection of anti-chromatin autoantibodies in systemic
lupus erythematosus in human serum.68 Nonspeciﬁc
immunoglobulin was detected showing promising applica-
bility of this simple and low-cost sensor. Chen et al. have
been fabricated an immunosensor to detect -fetoprotein,
using screen-printed carbon electrodes, anti--fetoprotein
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antibody, and glass ﬁber membranes conjugated with
ferrocene monocarboxylic acid-labeled -fetoprotein69 in
order to develop a robust sensor for point-of-care testing.
Detection limits as low as 6.0 ng mL−1 were achieved.
Disposable electrochemical immunosensors can also be
used in the detection of bacteria. For example, a very
sensitive immunosensor based on the electrochemical
enzymatic immunoassay using thiolated antibodies immo-
bilized on a gold surface has been proposed for the detec-
tion of Staphylococcal enterotoxin B.70 The authors studied
and compared some crosslinking agents for immobiliza-
tion of the capture antibody onto the gold electrode. The
immusensor was very speciﬁc and under the optimum
parameters, it exhibited a detection limit of 1 ng mL−1.
Immunosensors have also been developed for the detection
of Staphylococcus aureus in milk samples.71 In this case,
a detection limit of 14× 104 cells mL−1 was reported.
Zhao et al. proposed a new electrochemical immunosen-
sor based on horseradish peroxidase-labeled antibodies for
detection of Shigella ﬂexneri.72 The very low detection
limit exhibited by the sensors, viz.: 31× 103 cfu mL−1,
revealed the great potential of these systems for techno-
logical applications.
Also important to note is that a number of immunosen-
sor devices have also been used effectively in the deter-
mination of various hormones in human samples, such
as cortisol (Fig. 4),4273 testosterone,74 human growth
hormone (hGH),75 adrenocorticotropin,76 prolactin,41 and
estradiol.12 Regarding the ﬁeld of cardiology, immunosen-
sor devices have been employed for predicting the risk
of fatal cardiovascular diseases by sensing the nonspeciﬁc
biomarker C-reactive protein.7778 Silva et al. have been
designed an immunosensor to detect cardiac troponin T,
a speciﬁc biomarker for acute myocardial infarction.79 In
the latter study, the surface of screen-printed carbon elec-
trodes was modiﬁed with streptavidin polystyrene micro-
spheres to enhance sensitivity. The sensors presented a
detection limit of 0.2 ng mL−1 with potential for appli-
cations in point-of-care diagnostics. An immunosensor for
the detection of protein P-selectin, associated with cardiac
Figure 4. Schematic illustration of an impedimetric immunosensor for
cortisol based on an antibody immobilization onto Au microarray elec-
trode and a self-assembly monolayer using dithiobis(succinimidyl propi-
onate). Reprinted with permission from [64], S. K. Arya, et al., Biosens.
Bioelectron. 25, 2296 (2010). © 2010, Elsevier B.V.
diseases,80 has also been reported by Ho et al. In this
case, the authors developed a simple, disposable electro-
chemical sandwich immunosensor using a screen-printed
carbon electrode modiﬁed with carbon nanotubes and gold
nanobones. Detections limits of 0.85 pg mL−1 have been
reported.
3. DISPOSABLE DEVICES
FOR DNA DETECTION
The rapid progress of nanomedicine, especially in the
ﬁeld of medical diagnostics, has motivated the develop-
ment of new devices and/or arrays which can be combined
with biological materials for speciﬁc medical applications.
Genosensors based on electrochemical detection have been
a promising development in this area.81–86 These analyt-
ical devices exhibit high speciﬁcity and sensitivity and
can be applied for the early detection of many genetic
diseases, in pathology, food safety and in various other
ﬁelds.87 Disposable genosensors have gained considerable
importance in analytical chemistry since they employ DNA
hybridization for the early diagnoses of diseases by detect-
ing the oxidation signal of guanine/adenine or by using
the intercalation88 of dsDNA and ssDNA in a variety of
complexes containing aromatic condensed rings (antibi-
otics like clenbuterol8990 or metal coordination complexes
such as [Co(phen)3]
3+ or [Ru(bpy)3]2+9192.
The DNA bases, linked via hydrogen bonds, are located
on the inner side of the double helix and, hence, are inac-
cessible for reaction. The intercalators are used to over-
come the hindrance of electron transfer from the interior
of the double-stranded DNA to the electrode surface.93 An
increasing number and variety of disposable DNA sen-
sors have been developed in the recent years using new
materials as transducers for speciﬁc applications such as
gene polymorphism analysis. Owing to the high sensitivity
and compatibility with microfabrication chip technology,
carbon-based nanomaterials, including graphite, carbon
nanotubes or graphene have been used to produce dispos-
able genosensors. In most of these devices, carbon elec-
trodes were coupled with an electrochemical impedance
spectroscopy (EIS) system and DNA molecules to improve
the detected signal.9495 EIS generates electric signals in
the frequency domain, from the interactions of the immo-
bilized biomolecules,15 thereby improving the sensitiv-
ity of detection. The characterization and hybridization
of single- or double-stranded DNA layers can be per-
formed by measuring the current passing through an elec-
trochemical cell after the application of an AC potential.
Faradaic and non-Faradaic impedance spectroscopy analy-
ses are used to correlate the impedance signals to different
diseases.95
Disposable genosensors are used to detect pesticides,96
microbiological diseases,9798 toxic algae,99 and untreated
raw biological samples like serum and urine.100 DNA
sensors based on guanine oxidation have been reported
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to detect pesticides such as malathion and chlorpyri-
fos by monitoring changes in the DNA redox proper-
ties or by employing an electro-active analyte intercalated
on a DNA layer.96 Pencil graphite,96101102 carbon nano-
tubes modiﬁed with graphite,103–105 and screen-printed
graphite electrodes106107 were employed to monitor DNA
hybridization in speciﬁc sequences of Hepatitis B and C
virus for early diagnoses of the infectious agents.108
Understanding the binding interactions of DNA with
the drug molecules is an important area of research in
pharmaceutical development.109 Erdem et al. developed a
sensitive sepiolite-carbon nanotube device for the electro-
chemical detection of DNA and mitomycin C, an anti-
cancer antibiotic drug used in clinical chemotherapy. The
sepiolite mineral and carbon nanotubes improved the elec-
troactive surface area of the sensor electrodes and thereby
emerged as good candidates for clinical applications.110
Likewise, graphene oxide was integrated in an electro-
chemical device,111 which resulted in a decrease in the
guanine signal intensity due to the interaction of mito-
mycin C with DNA molecules, catalyzed by graphene.
Particular attention has been paid to the development of
disposable sensors capable of monitoring the interaction
Figure 5. Illustration of the magnetic genosensor developed by Loaiza, et al.: (1) formation of magnetic Fe@Au nanoparticles; (2) modiﬁcation of
Fe@Au with the thiolated probe; (3) hybridization with the biotinylated target; (4) enzymatic labeling with streptavidin-HRP; (5) hybrid-modiﬁed
magnetic bead deposition on the SPEs; (6) voltammetric detection of the mediated reduction of hydrogen peroxide with hydroquinone. Reprinted with
permission from [116], O. A. Loaiza, et al., Biosens. Bioelectron. 26, 2194 (2011). © 2011, Elsevier B.V.
between DNA and quinazoline molecules. These devices
have been used in various clinical applications as anti-
malarial agents and in cancer treatments.91112
Screen-printed carbon electrodes decorated with nano-
structures were used in the detection of bacterial
pathologies. The use of gold nanoparticles as the immo-
bilization and transduction surface enhanced the sensitiv-
ity and detection limit of the genosensor developed by
Martinez-Paredes, for the detection of bacteria associated
with respiratory tract infections such as Mycoplasma pneu-
moniae, Legionella pneumophila, Chlamydophila pneu-
moniae, andStreptococcus pneumonia.113 Oligonucleotide
molecules were adsorbed onto the screen-printed elec-
trodes using mercaptohexanol as a spacer in the detec-
tion of enterobacteriaceae lac Z, which is an indicator of
faecal contamination.114 A disposable magnetic genosen-
sor was also proposed by the same group of researchers
for the analysis of Escherichia coli DNA fragments by
enzyme-ampliﬁed coupling of streptavidin-peroxidase to
immobilized biotinylated lacZ gene target sequences.115
Loaiza et al. modiﬁed the above architecture using a mag-
netic ﬁeld on the surface of a home-made carbon screen-
printed electrode, as shown in Figure 5.116 Escherichia
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coli pathogen was used to develop a zirconium-modiﬁed
screen-printed genosensor. Methylene blue molecule was
employed as the redox indicator to analyze DNA immobi-
lization and hybridization.117
One of the most interesting disposable DNA sensors
was developed by Ahmed et al. by combining isothermal
ampliﬁcation with an electrochemical system to detect a
modiﬁed cry9c gene in a corn line118 (Maize line CBH
351 trade name StarLink™), banned for human consump-
tion. The products of loop-mediated isothermal ampliﬁca-
tion were combined with a redox active molecule, Hoechst
33258, and analyzed by a DNA stick integrated within an
electrochemical device as demonstrated in Figure 6. DNA
binding induced by Hoechst 33258 molecule, along with
changes in the anodic current peak, were used to detect
the modiﬁed cry9c gene variety with high efﬁciency.118
Disposable sensors were developed to detect the genetic
polymorphism for the purpose of diagnosis prior to the
onset of the disease symptoms; however, the sensibility
and selectivity of these devices still pose a challenge. Kara
et al. developed a genosensor capable of the allele-speciﬁc
electrical detection of toll-like receptor-2 gene arg753gln
Figure 6. Detection of modiﬁed cry9c gene using an electrochemical sensor: (1a) isothermal ampliﬁcation solution (LAMP) is placed into the
ampliﬁcation part of the chip along with the target DNA; (1b) chip detection site where the Hoechst 33258 molecule and buffer mixture are added;
(2) LAMP solution is placed on the heat block at 65 C for DNA ampliﬁcation; (3) valve is distorted to facilitate the mixing of fresh amplicon and
Hoechst 33258 in buffer solution; (4a) mixing of amplicon, Hoechst 33258 molecule, and buffer by mild shaking with hand; (4b) opening of the valve
in the chip; (5) inversion of the chip for electrochemical detection; (6a) connection of the chip to a potentiostat with the help of a connector; (6b)
schematic diagram exhibiting the interaction of DNA with Hoechst 33258, on the DEP chip surface made of polypropylene. Reprinted with permission
from [118], M. U. Ahmed, et al., Analyst 134, 966 (2009). © 2009, Royal Society of Chemistry.
polymorphism.119 The DNA probe was covalently immo-
bilized on a disposable graphite electrode surface. The
biosensor was able to detect the complementary sequence
and single nucleotide polymorphism in PCR ampliﬁed real
samples, using Meldola blue molecule as the hybridiza-
tion label. Development of analytical tools for the real
time detection of undesirable molecules in foodstuff is of
utmost importance in food industry. In order to investigate
the presence of hazelnut in foodstuffs, an electrochem-
ical DNA array combined with polymerase chain reac-
tion (PCR) has been designed using a gold screen-printed
electrode. The results were compared with those obtained
from enzyme-linked immunosorbent assay (ELISA) tests,
which indicated the applicability of the device for semi-
quantitative analysis.120
Low et al.121 developed a disposable horseradish perox-
idase based genosensor for the chronoamperometric detec-
tion of single-stranded asymmetric lolB gene from PCR
amplicon (118 bp in length), present in the food-borne
pathogen, Vibrio cholera causing the diarrheal disease
cholera. The analytical evaluation of the assay using 19
bacterial strains showed 100% speciﬁcity and a detection
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Figure 7. Customized gold-sputtered dual array electrodes with
attached chambers. Reprinted with permission from [124], E. Komarova,
et al., Biosens. Bioelectron. 25, 1389 (2010). © 2010, Elsevier.
limit as low as 0.85 ng/l of V. cholera genomic DNA.121
Genosensor devices have been implemented in the detec-
tion of polymorphism of real samples, for example, in the
detection of functional polymorphism in the catechol-
O-methyl transferase (COMT) gene from PCR ampli-
cons. Single nucleotide polymorphism (Val108/158Met)
in the COMT gene leads to various psychiatric disor-
ders such as schizophrenia, alcoholism, bipolar disorder,
and obsessive-compulsive disorder.122 The Val108/158Met
COMT genotype detection was performed on real sam-
ples containing healthy controls, and polymorphic and
PCR products. The detection limit of the biosensor was
2.4 pmol. A single-stranded oligonucleotide probe was
immobilized to detect the mutation in the COL4A5 gene123
causing Alport syndrome, which is a progressive renal dis-
ease affecting cochlear and ocular organs.
Komarova et al. developed a disposable multispeciﬁc
array based on the electrochemical impedance measure-
ments, using eight gold electrodes connected with a built-
in counter electrode and a reference electrode holder,124
as demonstrated in Figure 7. The array allowed the incor-
poration of multiple negative controls in the course of a
single binding experiment, and parallel experiments were
performed to improve the reliability of detection. These
features extend the application of these disposable point-
of-care sensors in biomedical research.
Yamanaka et al. demonstrated the use of a continuous-
ﬂow microﬂuidic RT-PCR chip connected with an electro-
chemical device for the rapid ampliﬁcation and sensing of
inﬂuenza (AH1pdm) virus. As observed in Figure 8, The
RT-PCR chip consisted of four distinct zones: RT reac-
tion zone, initial denaturation zone, thermal cycle zone for
PCR (2-step PCR) and pressurizing-channel zone. Methy-
lene blue molecules were used as DNA intercalators for
electrochemical measurements. These devices were inte-
grated into a microﬂuidic system and directly loaded onto
the DEP chips.125
The development of these disposables led to signiﬁcant
progress in the design of genosensors for the detection of
speciﬁc nucleotide sequences in nucleic acids of clinical,
food, and environmental interest. However, the need for
Figure 8. RT-PCR chip and DEP chip. (A) Chip layout. The channels
for the biochemical reactions are 50 mm deep and 50 mm wide, while the
pressurizing channels are 50 mm deep and 20 mm wide. The lengths of
the sections are as follows: RT reaction zone, 180 mm; initial denaturing
zone, 90 mm; thermal cycle zone, 930 mm (30 cycles); pressurizing-
channel zone, 80 mm. (B) Photograph of fabricated microﬂuidic chip.
(C) Photograph of DEP chip. Reprinted with permission from [125],
K. Yamanaka, et al., Analyst 136, 2064 (2011). © 2011, Royal Society
of Chemistry.
robustness and miniaturization of the devices poses a chal-
lenge in the development of these disposable devices.
4. POINT-OF-CARE DIAGNOSTICS
Point-of-care testing (POCT) involves rapid diagnostic
tests carried out at or near the site of patient care to
obtain immediate results.126 This type of diagnostic tool
is highly beneﬁcial in health management because of the
rapid disease diagnosis or dysfunctions. Disposable elec-
trochemical sensors and biosensors have signiﬁcant appli-
cations as diagnostic tools in the point-of-care testing.
The use of several disposable biosensors in the point-of-
care assessment of acetylcholinesterase,127 bacteria,128–131
cancer biomarkers,132–134 and DNA targets135 has been
reported in the literature. A portable sensor system com-
prising sixteen electrodes for DNA detection is illustrated
in Figure 9.
Rowe et al. have designed a ribonucleic acid-
based biosensor to detect gentamicin, an aminoglyco-
sidic antibiotic.136 The reported electrochemical biosensors
comprised an array of 32 gold electrodes that exhib-
ited rapid responses for point-of-care diagnostics in blood
serum samples. An electrochemical immunoassay for
detection of hippuric acid, one of major metabolites
in toluene-exposed humans, has been proposed by Yoo
et al. The authors used a portable microﬂuidic chip
with integrated microelectrodes made by screen-printing
hydrophilic carbon ink137 with the possibility of applica-
tion as point-of-care systems.
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Figure 9. Array of electrodes for point-of-care DNA detection using a complementary metal-oxide-semiconductor technology, developed by Levine,
et al. The authors applied a lab made potentiostat with sixteen sensing sites, each having an integrated current-input analog-to-digital converter (ADC)
to measure currents produced by electrochemical reactions occurring at the working electrodes. Reprinted with permission from [135], P. M. Levine,
et al., Biosens. Bioelectron. 24, 1995 (2009). © 2009, Elsevier.
Different strategies have been proposed for the detection
of cardiac biomarkers under the concept of point-of-care
diagnostics.129–135 For example, Jagadeesan et al. have
designed a low-cost and rapid method for the modiﬁcation
of paper electrodes with conducting polymers for the
amperometric detection of troponin138 for point-of-care
diagnosis. Polyaniline was deposited on the patterned
screen printed paper electrodes by electrodeposition,
followed by immobilization of anti-cardiac troponin-I
using 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide
hydrochloride and N -hydroxysuccinimide coupling.
A sensitivity of 5.5 A/ng mL−1 cm−2 was achieved in a
physiological range of 1–100 ng/mL.
Suprun et al. have been proposed an electrochemical
biosensor to quantify the myocardial infarction biomarker
myoglobin in human plasma.139 The method was based on
the direct electron transfer between Fe(III)-heme and the
transducer surface. The system comprised a screen-printed
graphite electrode modiﬁed with gold nanoparticles, dido-
decyldimethylammonium bromide and antibodies. The
proposed immunosensor presented a low detection limit
of 10 ng mL−1 and could be useful in the diagnosis
of acute myocardial infarction (Fig. 10). A disposable
electrochemical biosensor based on gold electrodes has
been fabricated by Carvalhal et al. for the detection of sal-
icylate in blood,140 using salicylate hydroxylase enzyme.
The portable biosensor was simple to prepare and exhib-
ited a great potential for application as disposable devices
for point-of-care diagnosis.
As described by Wu et al. aptamers are artiﬁcial, short,
single-stranded DNA/RNA oligonucleotides isolated from
random-sequence nucleic acid libraries by an in vitro
evolution process called systematic evolution of ligands
by exponential enrichment (SELEX).141 These oligonu-
cleotides have attracted considerable attention in the recent
years as they can recognize different targets with speciﬁc
properties and hence can be used as an economic, alter-
native detection tool in place of the traditional protein
antibodies. Indeed, McMullan et al. proposed the appli-
cation of an aptasensor as a highly sensitive, point-of-
care diagnostic tool for the detection of the blood clotting
enzyme thrombin, using covalently attached aptamers on
a gold electrode.142 An electrochemical aptasensor based
on graphene-3,4,9,10-perylenetetracarboxylic dianhydride
and functionalized hollow PtCo nanochains as enhancers
was developed for the ultrasensitive detection of thrombin
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Figure 10. Illustration of a disposable biosensor for myglobin
detection The system comprised a screen-printed graphite electrode mod-
iﬁed with gold nanoparticles stabilized in dodecyldimethylammonium
bromide (DDAB) and the antibody antimyoglobin (Anti-HMb). Reprinted
with permission from [139], E. Suprun, et al., Biosens. Bioelectron.
25, 1694 (2010). © 2010, Elsevier.
in clinical screening and point-of-care diagnostics.143 Dis-
posable systems for rapid diagnosis of infectious diseases
have been proposed.58136 In order to detect the inﬂuenza
virus H1N1, a virus affecting population across the world,
an electric immunoassay using immunochip modiﬁed with
carbon nanotubes was designed by Lee et al.144 A detec-
tion limit of 180 TCID50/ml of swine inﬂuenza virus (SIV)
was achieved.
5. FINAL REMARKS AND PERSPECTIVES
Disposable electrochemical sensors are of considerable
interest because of their efﬁcient application in obtaining
speciﬁc information in a faster, simpler, and cost-effective
manner, as opposed to the traditional analytical meth-
ods. Although signiﬁcant progress has been attained in
the development of disposable electrochemical devices for
medical application in recent years, this ﬁeld of research
is still at an early stage because of the challenges with
regard to stabilization of the biological molecules at the
platform and the miniaturization of the disposables with-
out loss of speciﬁcity and selectivity. Recent research has
focused on the development of miniaturized devices capa-
ble of mismatch discrimination and the use of transducers
for improving sensitivity and selectivity by signal ampli-
ﬁcation. To conclude, considerable attention should be
directed toward the development of immobilization pro-
cedures and the use of nanomaterials as graphene and
nanoparticles as transducers for signal ampliﬁcation. Inte-
gration of multiple devices on a single disposable platform
should lead to signiﬁcant advantages in terms of cost and
speed of the detection of a speciﬁc disease. It is expected
that the increased application of nanomaterials in the elec-
trochemical ﬁeld will lead to the development of new dis-
posables for the detection of different types of cancers,
along with other diseases like malaria, leishmaniasis and
dengue. Future research should emphasize on the develop-
ment and application of simple analytical devices for early
diagnosis in medical practice.
Acknowledgments: The authors acknowledge the
ﬁnancial support by Fundação de Amparo à Pesquisa do
Estado de São Paulo (FAPESP), Conselho Nacional de
Desenvolvimento Cientíﬁco e Tecnológico (CNPq) and
Coordenação de Aperfeiçoamento de Pessoal de Nível
Superior (CAPES).
References and Notes
1. L. C. S. Figueiredo, B. C. Janegitz, O. Fatibello, L. H. Marcolino,
and C. E. Banks, Anal. Methods 5, 202 (2013).
2. L. C. S. Figueiredo, B. C. Janegitz, R. C. Faria, O. Fatibello, L. H.
Marcolino, F. R. Caetano, and I. L. de Mattos, Quim. Nova 35, 1016
(2012).
3. C. Apetrei, P. Alessio, C. J. L. Constantino, J. A. de Saja,
M. L. Rodriguez-Mendez, F. J. Pavinatto, E. G. R. Fernandes,
V. Zucolotto, and O. N. Oliveira, Biosens. Bioelectron. 26, 2513
(2011).
4. F. J. Pavinatto, E. G. R. Fernandes, P. Alessio, C. J. L. Constantino,
J. A. de Saja, V. Zucolotto, C. Apetrei, O. N. Oliveira, and M. L.
Rodriguez-Mendez, J. Mater. Chem. 21, 4995 (2011).
5. A. C. Perinoto, R. M. Maki, M. C. Colhone, F. R. Santos,
V. Migliaccio, K. R. Daghastanli, R. G. Stabeli, P. Ciancaglini, F. V.
Paulovich, M. C. F. de Oliveira, O. N. Oliveira, and V. Zucolotto,
Anal. Chem. 82, 9763 (2010).
6. A. C. Perinotto, L. Caseli, C. O. Hayasaka, A. Riul, O. N. Oliveira,
and V. Zucolotto, Thin Solid Films 516, 9002 (2008).
7. V. Zucolotto, A. P. A. Pinto, T. Tumolo, M. L. Moraes, M. S.
Baptista, A. Riul, A. P. U. Araujo, and O. N. Oliveira, Biosens.
Bioelectron. 21, 1320 (2006).
8. F. V. Paulovich, R. M. Maki, M. C. F. de Oliveira, M. C. Colhone,
F. R. Santos, V. Migliaccio, P. Ciancaglini, K. R. Perez, R. G.
Stabeli, A. C. Perinoto, O. N. Oliveira, and V. Zucolotto, Anal.
Bioanal. Chem. 400, 1153 (2011).
9. B. C. Janegitz, R. A. Medeiros, R. C. Rocha, and O. Fatibello,
Diam. Rel. Mater. 25, 128 (2012).
10. B. C. Janegitz, R. Pauliukaite, M. E. Ghica, C. M. A. Brett, and
O. Fatibello, Sens. Actuator B-Chem. 158, 411 (2011).
11. L. Caseli, F. N. Crespilho, T. M. Nobre, M. E. D. Zaniquelli,
V. Zucolotto, and O. N. Oliveira, J. Colloid Interf. Sci. 319, 100
(2008).
12. I. Ojeda, J. Lopez-Montero, M. Moreno-Guzman, B. C. Janegitz,
A. Gonzalez-Cortes, P. Yanez-Sedeno, and J. M. Pingarron, Anal.
Chim. Acta 743, 117 (2012).
13. J. Wang, Microchimica Acta 177, 245 (2012).
14. J. R. Siqueira, M. H. Abouzar, A. Poghossian, V. Zucolotto, O. N.
Oliveira, and M. J. Schoning, Biosens. Bioelectron. 25, 497 (2009).
15. J. R. Siqueira, L. Caseli, F. N. Crespilho, V. Zucolotto, and O. N.
Oliveira, Biosens. Bioelectron. 25, 1254 (2010).
16. D. R. Thevenot, K. Toth, R. A. Durst, and G. S. Wilson, Biosens.
Bioelectron. 16, 121 (2001).
17. M. Mehrvar and M. Abdi, Anal. Sci. 20, 1113 (2004).
18. A. Amine, H. Mohammadi, I. Bourais, and G. Palleschi, Biosens.
Bioelectron. 21, 1405 (2006).
19. S. Cosnier, Anal. Bioanal. Chem. 377, 507 (2003).
20. A. C. Pierre, Biocatal. Biotransform. 22, 145 (2004).
21. X. Chu, D. X. Duan, G. L. Shen, and R. Q. Yu, Talanta 71, 2040
(2007).
22. Y. J. Zou, C. L. Xian, L. X. Sun, and F. Xu, Electrochim. Acta
53, 4089 (2008).
J. Nanosci. Nanotechnol. 14, 378–389, 2014 387
Delivered by Publishing Technology to: UNIVERSIDADE SAO PAULO IF
IP: 143.107.180.158 On: Tue, 28 Jan 2014 12:09:03
Copyright: American Scientific Publishers
Disposable Biosensors for Clinical Diagnosis Janegitz et al.
23. Z. M. Liu, Y. L. Liu, G. L. Shen, and R. Q. Yu, Anal. Lett. 41, 1083
(2008).
24. W. Siangproh, W. Dungchai, P. Rattanarat, and O. Chailapakul,
Anal. Chim. Acta 690, 10 (2011).
25. G. A. Rivas, M. D. Rubianes, M. C. Rodriguez, N. E. Ferreyra,
G. L. Luque, M. L. Pedano, S. A. Miscoria, and C. Parrado, Talanta
74, 291 (2007).
26. A. Qureshi, W. P. Kang, J. L. Davidson, and Y. Gurbuz, Diam. Rel.
Mater. 18, 1401 (2009).
27. N. Jha and S. Ramaprabhu, J. Nanosci. Nanotechnol. 9, 5676
(2009).
28. N. Jha and S. Ramaprabhu, J. Nanosci. Nanotechnol. 10, 2798
(2010).
29. A. L. Kavitha, H. G. Prabu, S. A. Babu, and S. K. Suja, J. Nanosci.
Nanotechnol. 13, 98 (2013).
30. R. Krishna, E. Titus, S. Chandra, N. K. Bardhan, D. Bahadur, and
J. Gracio, J. Nanosci. Nanotechnol. 12, 6631 (2012).
31. Y. Lei, X. Liu, X. Q. Yan, Y. Song, Z. Kang, N. Luo, and Y. Zhang,
J. Nanosci. Nanotechnol. 12, 513 (2012).
32. Y. L. Wang, Y. C. Zhu, Y. Y. Liu, Y. Yang, Q. C. Ruan, and F. F.
Xu, J. Nanosci. Nanotechnol. 10, 8286 (2010).
33. T. Ahuja, V. K. Tanwar, S. K. Mishra, D. Kumar, A. M. Biradar,
and Rajesh, J. Nanosci. Nanotechnol. 11, 4692 (2011).
34. S. Yan, X. Xu, Y. Sheng, H. Sun, J. Wu, and L. Tang, J. Nanosci.
Nanotechnol. 11, 10320 (2011).
35. M. Mishra, S. Alwarappan, R. K. Joshi, and T. Mohanty, J. Nanosci.
Nanotechnol. 13, 4040 (2013).
36. S. Marin and A. Merkoci, Electroanalysis 24, 459 (2012).
37. A. L. Liu, K. Wang, S. H. Weng, Y. Lei, L. Q. Lin, W. Chen, X. H.
Lin, and Y. Z. Chen, Trac.-Trend. Anal. Chem. 37, 101 (2012).
38. C. L. Morgan, D. J. Newman, and C. P. Price, Clin. Chem. 42, 193
(1996).
39. C. B. Jacobs, M. J. Peairs, and B. J. Venton, Anal. Chim. Acta
662, 105 (2010).
40. R. L. Caygill, G. E. Blair, and P. A. Millner, Anal. Chim. Acta
681, 8 (2010).
41. M. Moreno-Guzmán, A. González-Cortés, P. Yáñez-Sedeño, and
J. M. Pingarrón, Anal. Chim. Acta 692, 125 (2011).
42. M. Moreno-Guzman, M. Eguilaz, S. Campuzano, A. Gonzalez-
Cortes, P. Yanez-Sedeno, and J. M. Pingarron, Analyst 135, 1926
(2010).
43. L. T. N. Truong, M. Chikae, Y. Ukita, and Y. Takamura, Talanta
85, 2576 (2011).
44. S. S. Ordonez and E. Fabregas, Biosens. Bioelectron. 22, 965
(2007).
45. S. Sanchez, M. Pumera, and E. Fabregas, Biosens. Bioelectron.
23, 332 (2007).
46. Z. Z. Yin, R. J. Cui, Y. Liu, L. P. Jiang, and J. J. Zhu, Biosens.
Bioelectron. 25, 1319 (2010).
47. C. Leng, J. Wu, Q. N. Xu, G. S. Lai, H. X. Jua, and F. Yan, Biosens.
Bioelectron. 27, 71 (2011).
48. H. Wu, Z. Zhang, Z. F. Fu, and H. X. Ju, Biosens. Bioelectron.
23, 114 (2007).
49. J. Wu, F. Yan, X. Q. Zhang, Y. T. Yan, J. H. Tang, and H. X. Ju,
Clin. Chem. 54, 1481 (2008).
50. J. A. A. Ho, Y. C. Lin, L. S. Wang, K. C. Hwang, and P. T. Chou,
Anal. Chem. 81, 1340 (2009).
51. S. Viswanathan, C. Rani, A. Vijay Anand, and J.-A. A. Ho, Biosens.
Bioelectron. 24, 1984 (2009).
52. Y. Y. Lin, G. D. Liu, C. M. Wai, and Y. H. Lin, Anal. Chim. Acta
612, 23 (2008).
53. K. J. Huang, D. J. Niu, W. Z. Xie, and W. Wang, Anal. Chim. Acta
659, 102 (2010).
54. S. G. Ge, L. Ge, M. Yan, X. R. Song, J. H. Yu, and J. D. Huang,
Chem. Commun. 48, 9397 (2012).
55. J. T. La Belle, K. Bhavsar, A. Fairchild, A. Das, J. Sweeney, T. L.
Alford, J. Wang, V. P. Bhavanandan, and L. Joshi, Biosens. Bio-
electron. 23, 428 (2007).
56. G. S. Lai, F. Yan, and H. X. Ju, Anal. Chem. 81, 9730 (2009).
57. G. S. Lai, L. L. Wang, J. Wu, H. X. Ju, and F. Yan, Anal. Chim.
Acta 721, 1 (2012).
58. C. K. Tang, A. Vaze, and J. F. Rusling, Lab Chip 12, 281 (2012).
59. J. A. A. Ho, H. C. Chang, N. Y. Shih, L. C. Wu, Y. F. Chang, C. C.
Chen, and C. Chou, Anal. Chem. 82, 5944 (2010).
60. A. Zani, S. Laschi, M. Mascini, and G. Marrazza, Electroanalysis
23, 91 (2011).
61. H. Wang, J. Wang, C. Timchalk, and Y. H. Lin, Anal. Chem.
80, 8477 (2008).
62. G. Y. Zhao and X. J. Zhan, Electrochim. Acta 55, 2466 (2010).
63. K. Omidfar, A. Dehdast, H. Zarei, B. K. Sourkohi, and B. Larijani,
Biosens. Bioelectron. 26, 4177 (2011).
64. L. Bone, J. C. Vidal, P. Duato, and J. R. Castillo, Anal. Methods
2, 335 (2010).
65. Y. H. Lin, S. H. Chen, Y. C. Chuang, Y. C. Lu, T. Y. Shen, C. A.
Chang, and C. S. Lin, Biosens. Bioelectron. 23, 1832 (2008).
66. F. H. Zhang, S. H. Yang, T. Y. Kang, G. S. Cha, H. Nam, and M. E.
Meyerhoff, Biosens. Bioelectron. 22, 1419 (2007).
67. K. Bhavsar, A. Fairchild, E. Alonas, D. K. Bishop, J. T. La Belle,
J. Sweeney, T. L. Alford, and L. Joshi, Biosens. Bioelectron. 25, 506
(2009).
68. K. N. Konstantinov, R. A. Sitdikov, G. P. Lopez, P. Atanassov, and
R. L. Rubin, Biosens. Bioelectron. 24, 1949 (2009).
69. Z. C. Chen, C. Fang, H. Y. Wang, J. S. He, and Z. S. Deng, Sens.
Actuator B-Chem. 141, 436 (2009).
70. M. P. Chatrathi, J. Wang, and G. E. Collins, Biosens. Bioelectron.
22, 2932 (2007).
71. V. Escamilla-Gomez, S. Campuzano, M. Pedrero, and J. M.
Pingarron, Talanta 77, 876 (2008).
72. G. Y. Zhao, X. J. Zhan, and W. C. Dou, Anal. Biochem. 408, 53
(2011).
73. S. K. Arya, G. Chornokur, M. Venugopal, and S. Bhansali, Biosens.
Bioelectron. 25, 2296 (2010).
74. M. Eguilaz, M. Moreno-Guzman, S. Campuzano, A. Gonzalez-
Cortes, P. Yanez-Sedeno, and J. M. Pingarron, Biosens. Bioelectron.
26, 517 (2010).
75. V. Seraﬁn, N. Ubeda, L. Agui, P. Yanez-Sedeno, and J. M.
Pingarron, Anal. Bioanal. Chem. 403, 939 (2012).
76. M. Moreno-Guzman, I. Ojeda, R. Villalonga, A. Gonzalez-Cortes,
P. Yanez-Sedeno, and J. M. Pingarron, Biosens. Bioelectron. 35, 82
(2012).
77. M. Buch and J. Rishpon, Electroanalysis 20, 2592 (2008).
78. Z. H. Ibupoto, N. Jamal, K. Khun, and M. Willander, Sens. Actuator
B-Chem. 166, 809 (2012).
79. B. V. M. Silva, I. T. Cavalcanti, A. B. Mattos, P. Moura, M. D.
T. Sotomayor, and R. F. Dutra, Biosens. Bioelectron. 26, 1062
(2010).
80. J. A. A. Ho, A. F. J. Jou, L. C. Wu, and S. L. Hsu, Methods 56, 223
(2012).
81. E. Farjami, L. Clima, K. Gothelf, and E. E. Ferapontova, Anal.
Chem. 83, 1594 (2011).
82. A. Bonanni, and M. Pumera, Acs Nano 5, 2356 (2011).
83. R. Miranda-Castro, N. de-los-Santos-Alvarez, M. Jesus Lobo-
Castanon, A. J. Miranda-Ordieres, and P. Tunon-Blanco, Electro-
analysis 21, 2077 (2009).
84. F. Lucarelli, S. Tombelli, M. Minunni, G. Marrazza, and
M. Mascini, Anal. Chim. Acta 609, 139 (2008).
85. M. T. Castaneda, S. Alegret, and A. Merkoci, Electroanalysis
19, 743 (2007).
86. M. S. Yang, M. E. McGovern, and M. Thompson, Anal. Chim. Acta
346, 259 (1997).
87. A. Sassolas, B. D. Leca-Bouvier, and L. J. Blum, Chem. Rev.
108, 109 (2008).
388 J. Nanosci. Nanotechnol. 14, 378–389, 2014
Delivered by Publishing Technology to: UNIVERSIDADE SAO PAULO IF
IP: 143.107.180.158 On: Tue, 28 Jan 2014 12:09:03
Copyright: American Scientific Publishers
Janegitz et al. Disposable Biosensors for Clinical Diagnosis
88. A. Erdem, Talanta 74, 318 (2007).
89. G. Liu, H. Chen, H. Peng, S. Song, J. Gao, J. Lu, M. Ding, L. Li,
S. Ren, Z. Zou, and C. Fan, Biosens. Bioelectron. 28, 308 (2011).
90. K. Kerman, M. Kobayashi, and E. Tamiya, Meas. Sci. Technol.
15, R1 (2004).
91. J. Labuda, R. Ovadekova, and J. Galandova, Microchim. Acta
164, 371 (2009).
92. P. Kara, K. Kerman, D. Ozkan, B. Meric, A. Erdem, Z. Ozkan, and
M. Ozsoz, Electrochem. Commun. 4, 705 (2002).
93. A. M. Oliveira-Brett, Electrochemical DNA Assays, John Wiley &
Sons, Ltd., England (2008).
94. F. Lucarelli, G. Marrazza, A. P. F. Turner, and M. Mascini, Biosens.
Bioelectron. 19, 515 (2004).
95. A. Bonanni and M. del Valle, Anal. Chim. Acta 678, 7 (2010).
96. N. Prabhakar, K. Arora, S. P. Singh, M. K. Pandey, H. Singh, and
B. D. Malhotra, Anal. Chim. Acta 589, 6 (2007).
97. M. H. Pournaghi-Azar, F. Ahour, and M. S. Hejazi, Electroanalysis
21, 1822 (2009).
98. Y. Zhuo, R. Yuan, Y. Q. Chai, Y. Zhang, X. L. Li, Q. Zhu, and
N. Wang, Anal. Chim. Acta 548, 205 (2005).
99. S. Diercks, K. Metﬁes, and L. K. Medlin, Biosens. Bioelectron.
23, 1527 (2008).
100. F. Kuralay, S. Campuzano, D. A. Haake, and J. Wang, Talanta
85, 1330 (2011).
101. A. Erdem, F. Sayar, H. Karadeniz, G. Guven, M. Ozsoz, and
E. Piskin, Electroanalysis 19, 798 (2007).
102. S. Mathur, A. Erdem, C. Cavelius, S. Barth, and J. Altmayer, Sens.
Actuator B-Chem. 136, 432 (2009).
103. H. Karadeniz, A. Erdem, and A. Caliskan, Electroanalysis 20, 1932
(2008).
104. A. Caliskan, A. Erdem, and H. Karadeniz, Electroanalysis 21, 2116
(2009).
105. A. Erdem, P. Papakonstantinou, H. Murphy, M. McMullan,
H. Karadeniz, and S. Sharma, Electroanalysis 22, 611 (2010).
106. H. Karadeniz, A. Erdem, F. Kuralay, and F. Jelen, Talanta 78, 187
(2009).
107. C. D. S. Riccardi, C. Kranz, J. Kowalik, H. Yamanaka,
B. Mizaikoff, and M. Josowicz, Anal. Chem. 80, 237 (2008).
108. P. Kara, S. Cavdar, B. Meric, S. Erensoy, and M. Ozsoz, Bioelec-
trochemistry 71, 204 (2007).
109. E. Yapasana, A. Caliskan, H. Karadeniz, and A. Erdem, Mater. Sci.
Eng., B 169, 169 (2010).
110. A. Erdem, F. Kuralay, H. E. Cubukcu, G. Congur, H. Karadeniz,
and E. Canavar, Analyst 137, 4001 (2012).
111. A. Erdem, M. Muti, P. Papakonstantinou, E. Canavar, H. Karadeniz,
G. Congur, and S. Sharma, Analyst 137, 2129 (2012).
112. J. Galandova, R. Ovadekova, A. Ferancova, and J. Labuda, Anal.
Bioanal. Chem. 394, 855 (2009).
113. G. Martinez-Paredes, M. Begona Gonzalez-Garcia, and A. Costa-
Garcia, Sens. Actuator B-Chem. 149, 329 (2010).
114. O. A. Loaiza, S. Campuzano, M. Pedrero, and J. M. Pingaron,
Electroanalysis 20, 1397 (2008).
115. O. A. Loaiza, S. Campuzano, M. Pedrero, M. I. Pividori, P. Garcia,
and J. M. Pingarron, Anal. Chem. 80, 8239 (2008).
116. O. A. Loaiza, E. Jubete, E. Ochoteco, G. Cabanero, H. Grande, and
J. Rodriguez, Biosens. Bioelectron. 26, 2194 (2011).
117. S.-H. Zuo, L.-F. Zhang, Y.-H. Zhao, H.-H. Yuan, M.-B. Lan, G. A.
Lawrance, and G. Wei, Aust. J. Chem. 61, 962 (2008).
118. M. U. Ahmed, M. Saito, M. M. Hossain, S. R. Rao, S. Furui,
A. Hino, Y. Takamura, M. Takagi, and E. Tamiya, Analyst 134, 966
(2009).
119. P. Kara, S. Cavdar, A. Berdeli, and M. Ozsoz, Electroanalysis
19, 1875 (2007).
120. F. Bettazzi, F. Lucarelli, I. Palchetti, F. Berti, G. Marrazza, and
M. Mascini, Anal. Chim. Acta 614, 93 (2008).
121. K.-F. Low, K. Chuenrangsikul, P. Rijiravanich, W. Surareungchai,
and Y.-Y. Chan, World J. Microbiol. Biotechnol. 28, 1699 (2012).
122. D. Ozkan-Ariksoysal, B. Tezcanli, B. Kosova, and M. Ozsoz, Anal.
Chem. 80, 588 (2008).
123. A. Bonanni, M. Pumera, and Y. Miyahara, Anal. Chem. 82, 3772
(2010).
124. E. Komarova, K. Reber, M. Aldissi, and A. Bogomolova, Biosens.
Bioelectron. 25, 1389 (2010).
125. K. Yamanaka, M. Saito, K. Kondoh, M. M. Hossain, R. Koketsu,
T. Sasaki, N. Nagatani, K. Ikuta, and E. Tamiya, Analyst 136, 2064
(2011).
126. G. J. Kost, Principles and Practices of Point-of-Care Testing, Lip-
pincott Williams & Wilkins, Hagerstwon, Philadelphia (2002).
127. D. Du, J. Wang, L. M. Wang, D. L. Lu, and Y. H. Lin, Anal. Chem.
84, 1380 (2012).
128. X. F. Guo, A. Kulkarni, A. Doepke, H. B. Halsall, S. Iyer, and
W. R. Heineman, Anal. Chem. 84, 241 (2012).
129. M. Safavieh, M. U. Ahmed, M. Tolba, and M. Zourob, Biosens.
Bioelectron. 31, 523 (2012).
130. Y. Yang, S. Kim, and J. Chae, J. Microelectromech. Syst. 20, 819
(2011).
131. J. Wojciechowski, D. Danley, J. Cooper, N. Yazvenko, and C. R.
Taitt, Sensors 10, 3351 (2010).
132. D. Du, Z. X. Zou, Y. S. Shin, J. Wang, H. Wu, M. H. Engelhard,
J. Liu, I. A. Aksay, and Y. H. Lin, Anal. Chem. 82, 2989 (2010).
133. V. J. Nagaraj, S. Aithal, S. Eaton, M. Bothara, P. Wiktor, and
S. Prasad, Nanomedicine 5, 369 (2010).
134. P. P. Wang, L. Ge, M. Yan, X. R. Song, S. G. Ge, and J. H. Yu,
Biosens. Bioelectron. 32, 238 (2012).
135. P. M. Levine, P. Gong, R. Levicky, and K. L. Shepard, Biosens.
Bioelectron. 24, 1995 (2009).
136. A. A. Rowe, E. A. Miller, and K. W. Plaxco, Anal. Chem. 82, 7090
(2010).
137. S. J. Yoo, Y. B. Choi, J. Il Ju, G. S. Tae, H. H. Kim, and S. H.
Lee, Analyst 134, 2462 (2009).
138. K. K. Jagadeesan, S. Kumar, and G. Sumana, Electrochem. Com-
mun. 20, 71 (2012).
139. E. Suprun, T. Bulko, A. Lisitsa, O. Gnedenko, A. Ivanov,
V. Shumyantseva, and A. Archakov, Biosens. Bioelectron. 25, 1694
(2010).
140. R. F. Carvalhal, D. S. Machado, R. K. Mendes, A. L. J. Almeida,
N. H. Moreira, M. H. O. Piazetta, A. L. Gobbi, and L. T. Kubota,
Biosens. Bioelectron. 25, 2200 (2010).
141. Z. S. Wu, H. Zhou, S. B. Zhang, G. L. Shen, and R. Q. Yu, Anal.
Chem. 82, 2282 (2010).
142. M. McMullan, N. J. Sun, P. Papakonstantinou, M. X. Li, W. Z.
Zhou, and D. Mihailovic, Biosens. Bioelectron. 26, 1853 (2011).
143. K. F. Peng, H. W. Zhao, X. F. Wu, Y. L. Yuan, and R. Yuan, Sens.
Actuator B-Chem. 169, 88 (2012).
144. D. J. Lee, Y. Chander, S. M. Goyal, and T. H. Cui, Biosens. Bio-
electron. 26, 3482 (2011).
Received: 24 October 2013. Accepted: 26 November 2013.
J. Nanosci. Nanotechnol. 14, 378–389, 2014 389
